MedScout Raises $10M Growth Round, Launches AI Agents for MedTech Sales Teams

The Austin-based company also announced the launch of “Strategies,” AI agents designed to support MedTech commercial teams in translating strategy into field execution.

MedScout has raised $10 million in a growth funding round led by Fulcrum Equity Partners, with participation from Live Oak Venture Partners and Stage 2 Capital. The Austin-based company also announced the launch of “Strategies,” AI agents designed to support MedTech commercial teams in translating strategy into field execution.

The company said the round more than doubled its valuation from its Series A in July 2024. Proceeds will be used to expand MedScout’s artificial intelligence capabilities and meet growing enterprise demand.

MedScout develops AI-driven tools aimed at addressing a persistent gap in MedTech organizations, where commercial strategy is set centrally but often fails to translate effectively to frontline sales teams. Its newly launched Strategies product analyzes market data, referral networks, procedure volumes, and payer dynamics to generate prioritized territory plans for representatives.

According to Skylar Talley, co-founder and CEO of MedScout, the platform is designed to convert high-level commercial priorities into territory-specific actions, helping representatives identify providers and accounts most likely to convert.

The company reported that enterprise revenue has grown threefold since its Series A. Monthly active representatives increased 135% month over month, while customers deployed 81% more unique AI agents in January compared to the previous month.

Each AI agent is configured around a company’s commercial positioning and target definitions. MedScout said the system draws on field-tested patterns developed through work with hundreds of MedTech commercial teams.

Use cases include identifying surgeons with high procedure volumes who have not adopted specific technologies, analyzing referral leakage patterns within defined geographic radii, and flagging hospitals with declining procedure volumes despite strong baseline capacity. The goal is to provide ranked, actionable account lists aligned with growth priorities.

Philip Lewis, Partner at Fulcrum Equity Partners, said the investment reflects confidence in MedScout’s approach to integrating AI into commercial execution workflows.

MedScout stated it is actively deploying Strategies across MedTech commercial teams as organizations seek to improve alignment between corporate strategy and sales performance.

Stay tuned for more such updates on Digital Health News